✦ LIBER ✦

Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study

✍ Scribed by Ann E Traynor; James Schroeder; Robert M Rosa; Dong Cheng; Jakub Stefka; Salim Mujais; Steven Baker; Richard K Burt

Book ID: 117275874
Publisher: The Lancet
Year: 2000
Tongue: English
Weight: 263 KB
Volume: 356
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(00)02627-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment and follow-up of 18 severe sys

Treatment and follow-up of 18 severe systemic lupus erythematosus patients with stem cell transplantation

✍ LENG, XiaoMei ;ZHAO, Yan ;ZHOU, DaoBing ;TIAN, XinPing ;LI, TaiSheng ;SHEN, Ti ; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Phase I/II study of tandem high-dose che

Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma

✍ Kazutaka Sunami; Katsuji Shinagawa; Morio Sawamura; Akira Sakai; Yoshio Saburi; 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 277 KB

B cell depletion as a novel treatment fo

B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose-escalation trial of rituximab

✍ R. John Looney; Jennifer H. Anolik; Debbie Campbell; Raymond E. Felgar; Faith Yo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Abstract ## Objective Safer and more effective therapies are needed for the treatment of systemic lupus erythematosus (SLE). B lymphocytes have been shown to play fundamental pathogenic roles in SLE, and therefore, elimination of B cells with the use of rituximab may represent a new therapy for

Successful treatment of intravascular ma

Successful treatment of intravascular malignant lymphomatosis with high-dose chemotherapy and autologous peripheral blood stem cell transplantation

✍ Koizumi, M; Nishimura, M; Yokota, A; Munekata, S; Kobayashi, T; Saito, Y 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 41 KB

A phase i/ii study of 166holmium-dotmp i

A phase i/ii study of 166holmium-dotmp in combination with high dose chemotherapy and autologous stem cell transplant(Asct) For the treatment of patients with multiple myeloma(Mm)

✍ W. Bensinger; S. Giralt; J. Eary; D. Podoloff; L. Holmberg; R. Alexanian; M. Goo 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 15 KB

Possible benefits of high-dose chemother

Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma

✍ Zia, M I; Forsyth, P; Chaudhry, A; Russell, J; Stewart, D A 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 121 KB